共 19 条
[1]
PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
[J].
ARTHRITIS AND RHEUMATISM,
1980, 23 (05)
:581-590
[3]
Baroni SS, 2006, NEW ENGL J MED, V354, P2667
[4]
Chung L, 2010, AM COLL RHEUM ANN SC
[5]
Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis
[J].
ARTHRITIS AND RHEUMATISM,
2009, 60 (02)
:584-591
[6]
CLEMENTS P, 1995, J RHEUMATOL, V22, P1281
[7]
Distler O, 2010, AM COLL RHEUM ANN SC
[9]
Mechanisms of Disease: Scleroderma.
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
2009, 360 (19)
:1989-2003
[10]
A One-Year, Phase I/IIa, Open-Label Pilot Trial of Imatinib Mesylate in the Treatment of Systemic Sclerosis-Associated Active Interstitial Lung Disease
[J].
ARTHRITIS AND RHEUMATISM,
2011, 63 (11)
:3540-3546